Literature DB >> 20148794

The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.

Allison M Salmon1, Ingrid van Beek, Janaki Amin, John Kaldor, Lisa Maher.   

Abstract

AIMS: Supervised injecting facilities (SIFs) are effective in reducing the harms associated with injecting drug use among their clientele, but do SIFs ease the burden on ambulance services of attending to overdoses in the community? This study addresses this question, which is yet to be answered, in the growing body of international evidence supporting SIFs efficacy.
DESIGN: Ecological study of patterns in ambulance attendances at opioid-related overdoses, before and after the opening of a SIF in Sydney, Australia.
SETTING: A SIF opened as a pilot in Sydney's 'red light' district with the aim of accommodating a high throughput of injecting drug users (IDUs) for supervised injecting episodes, recovery and the management of overdoses. MEASUREMENTS: A total of 20,409 ambulance attendances at opioid-related overdoses before and after the opening of the Sydney SIF. Average monthly ambulance attendances at suspected opioid-related overdoses, before (36 months) and after (60 months) the opening of the Sydney Medically Supervised Injecting Centre (MSIC), in the vicinity of the centre and in the rest of New South Wales (NSW).
RESULTS: The burden on ambulance services of attending to opioid-related overdoses declined significantly in the vicinity of the Sydney SIF after it opened, compared to the rest of NSW. This effect was greatest during operating hours and in the immediate MSIC area, suggesting that SIFs may be most effective in reducing the impact of opioid-related overdose in their immediate vicinity.
CONCLUSIONS: By providing environments in which IDUs receive supervised injection and overdose management and education SIF can reduce the demand for ambulance services, thereby freeing them to attend other medical emergencies within the community.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148794     DOI: 10.1111/j.1360-0443.2009.02837.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  19 in total

1.  Does evidence support supervised injection sites?

Authors:  Jennifer Ng; Christy Sutherland; Michael R Kolber
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

Review 2.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

3.  City checking: Piloting the UK's first community-based drug safety testing (drug checking) service in 2 city centres.

Authors:  Fiona Measham
Journal:  Br J Clin Pharmacol       Date:  2020-02-17       Impact factor: 4.335

4.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

5.  Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.

Authors:  Lianping Ti; Jane Buxton; Scott Harrison; Sabina Dobrer; Julio Montaner; Evan Wood; Thomas Kerr
Journal:  J Hosp Med       Date:  2015-03-05       Impact factor: 2.960

6.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

Review 7.  Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.

Authors:  Kinna Thakarar; Katherine Nenninger; Wollelaw Agmas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

8.  Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.

Authors:  Sanjana Mitra; Beth Rachlis; Ayden Scheim; Geoff Bardwell; Sean B Rourke; Thomas Kerr
Journal:  Harm Reduct J       Date:  2017-07-14

9.  Risk environments facing potential users of a supervised injection site in Ottawa, Canada.

Authors:  Ashley Shaw; Lisa Lazarus; Tyler Pantalone; Sean LeBlanc; Dolly Lin; Daina Stanley; Caleb Chepesiuk; Sheetal Patel; Mark Tyndall
Journal:  Harm Reduct J       Date:  2015-10-22

10.  Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.

Authors:  Andrew McAuley; Janet Bouttell; Lee Barnsdale; Daniel Mackay; Jim Lewsey; Carole Hunter; Mark Robinson
Journal:  Addiction       Date:  2016-11-06       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.